title: Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.
abstract: Longitudinal MRI was applied to monitor intracranial initiation and development of brain metastases and assess tumor vascular volume and permeability in a mouse model of breast cancer brain metastases. Using a 9.4T system, high resolution anatomic MRI and dynamic susceptibility contrast (DSC) perfusion MRI were acquired at different time points after an intracardiac injection of brain-tropic breast cancer MDA-MB231BR-EGFP cells. Three weeks post injection, multifocal brain metastases were first observed with hyperintensity on T2-weighted images, but isointensity on T1-weighted post contrast images, indicating that blood-tumor-barrier (BTB) at early stage of brain metastases was impermeable. Follow-up MRI revealed intracranial tumor growth and increased number of metastases that distributed throughout the whole brain. At the last scan on week 5, T1-weighted post contrast images detected BTB disruption in 160 (34%) of a total of 464 brain metastases. Enhancement in some of the metastases was only seen in partial regions of the tumor, suggesting intratumoral heterogeneity of BTB disruption. DSC MRI measurements of relative cerebral blood volume (rCBV) showed that rCBV of brain metastases was significantly lower (mean= 0.89±0.03) than that of contralateral normal brain (mean= 1.00±0.03; p<0.005). Intriguingly, longitudinal measurements revealed that rCBV of individual metastases at early stage was similar to, but became significantly lower than that of contralateral normal brain with tumor growth (p<0.05). The rCBV data were concordant with histological analysis of microvascular density (MVD). Moreover, comprehensive analysis suggested no significant correlation among tumor size, rCBV and BTB permeability. In conclusion, longitudinal MRI provides non-invasive in vivo assessments of spatial and temporal development of brain metastases and their vascular volume and permeability. The characteristic rCBV of brain metastases may have a diagnostic value.
authors: Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
authors: Heling
authors: H
authors: Zhou
authors: Min
authors: M
authors: Chen
authors: Dawen
authors: D
authors: Zhao
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000378:metabolism* / Q000473:pathology*; D001932:Brain Neoplasms / Q000098:blood supply* / Q000175:diagnosis / Q000473:pathology* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology*; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D005260:Female; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D051379:Mice; D008819:Mice, Nude
references: Nat Med. 2010 Jan;16(1):116-22
references: 20023634
references: Pharmacol Ther. 2004 Oct;104(1):29-45
references: 15500907
references: J Neurooncol. 2008 Jul;88(3):359-65
references: 18398574
references: Cancer. 2002 May 15;94(10):2698-705
references: 12173339
references: Magn Reson Med. 1991 Dec;22(2):293-9; discussion 300-3
references: 1812360
references: Radiology. 1994 Apr;191(1):41-51
references: 8134596
references: Magn Reson Med. 1988 Feb;6(2):164-74
references: 3367774
references: Lancet Oncol. 2002 Aug;3(8):498-507
references: 12147436
references: J Clin Oncol. 2004 Sep 1;22(17):3608-17
references: 15337811
references: J Transl Med. 2009 Oct 20;7:88
references: 19840404
references: J Bone Miner Res. 2001 Aug;16(8):1486-95
references: 11499871
references: Radiology. 1999 Jun;211(3):791-8
references: 10352608
references: Am J Pathol. 2010 Jun;176(6):2958-71
references: 20382702
references: Nat Rev Cancer. 2011 Feb;11(2):135-41
references: 21258397
references: Cancer Res. 2007 May 1;67(9):4190-8
references: 17483330
references: N Engl J Med. 2004 Jun 3;350(23):2335-42
references: 15175435
references: Lancet Oncol. 2002 Jan;3(1):53-7
references: 11905606
references: Magn Reson Med. 2004 May;51(5):961-8
references: 15122678
references: Nat Rev Clin Oncol. 2011 Jun;8(6):344-56
references: 21487419
references: Am J Pathol. 1992 Nov;141(5):1115-24
references: 1443046
references: Nat Rev Cancer. 2011 May;11(5):352-63
references: 21472002
references: Radiology. 2008 Apr;247(1):170-8
references: 18372467
references: Magn Reson Med. 1995 Sep;34(3):293-301
references: 7500865
references: Invest Radiol. 2007 Sep;42(9):629-35
references: 17700278
references: Clin Cancer Res. 2010 Dec 1;16(23):5664-78
references: 20829328
references: Int J Cancer. 2007 Aug 15;121(4):901-7
references: 17437269
references: Neurosurgery. 2005 Nov;57(5 Suppl):S54-65; discusssion S1-4
references: 16237290
references: Invest Radiol. 2011 Nov;46(11):718-25
references: 21788908
references: Cancer Res. 2002 Jan 15;62(2):341-5
references: 11809675
references: PLoS One. 2009 Jun 10;4(6):e5857
references: 19516901
references: Magn Reson Med. 2003 May;49(5):848-55
references: 12704767
references: Magn Reson Med. 1998 Sep;40(3):348-55
references: 9727936
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):421-8
references: 15701824
references: Cancer. 2003 Jun 15;97(12):2972-7
references: 12784331